Anavex Life Sciences Corp... (AVXL)
NASDAQ: AVXL
· Real-Time Price · USD
9.48
-0.09 (-0.94%)
At close: Jun 27, 2025, 3:59 PM
9.25
-2.43%
After-hours: Jun 27, 2025, 05:38 PM EDT
-0.94% (1D)
| Bid | 8.8 |
| Market Cap | 809.32M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -35.95M |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -16.93 |
| Forward PE | 6.67 |
| Analyst | Buy |
| Ask | 9.7 |
| Volume | 476,623 |
| Avg. Volume (20D) | 936,419 |
| Open | 9.66 |
| Previous Close | 9.57 |
| Day's Range | 9.30 - 9.75 |
| 52-Week Range | 4.00 - 14.44 |
| Beta | 0.67 |
About AVXL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AVXL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AVXL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+8.21%
Anavex Life Sciences shares are trading higher aft...
Unlock content with
Pro Subscription
6 months ago
+29.55%
Anavex Life Sciences shares are trading higher after the company announced better-than-expected Q4 financial results.
1 month ago · seekingalpha.com
Anavex Life Sciences Corp. (AVXL) Q2 2025 Earnings Call TranscriptAnavex Life Sciences Corp. (NASDAQ:AVXL ) Q2 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Clint Tomlinson - Investor Relations Christopher Missling - President & Chief Ex...